Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Operating Leases (2020 - 2025)

Historic Operating Leases for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $10.3 million.

  • RxSight's Operating Leases fell 281.93% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 281.93%. This contributed to the annual value of $11.3 million for FY2024, which is 83492.98% up from last year.
  • RxSight's Operating Leases amounted to $10.3 million in Q3 2025, which was down 281.93% from $10.6 million recorded in Q2 2025.
  • Over the past 5 years, RxSight's Operating Leases peaked at $11.3 million during Q4 2024, and registered a low of $908000.0 during Q1 2024.
  • Over the past 5 years, RxSight's median Operating Leases value was $3.7 million (recorded in 2021), while the average stood at $5.4 million.
  • As far as peak fluctuations go, RxSight's Operating Leases crashed by 6116.34% in 2024, and later surged by 111002.2% in 2025.
  • Quarter analysis of 5 years shows RxSight's Operating Leases stood at $3.6 million in 2021, then decreased by 21.58% to $2.9 million in 2022, then crashed by 57.6% to $1.2 million in 2023, then skyrocketed by 834.93% to $11.3 million in 2024, then decreased by 9.27% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $10.6 million for Q2 2025, and $11.0 million during Q1 2025.